Latest Articles
Sentinel Node Biopsy Gains Ground in Endometrial Cancer - medscape.com
Sentinel Node Biopsy Gains Ground in Endometrial Cancer medscape.com
Published: Aug. 6, 2026, 12:34 p.m.
Study finds racial differences in ultrasound evaluation of suspected endometrial cancer - Bioengineer.org
Study finds racial differences in ultrasound evaluation of suspected endometrial cancer Bioengineer.org
Published: Aug. 4, 2026, 4:58 p.m.
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer - Clinical Oncology News
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer Clinical Oncology News
Published: Aug. 3, 2026, 3:32 p.m.
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer - clinicaloncology.com
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer clinicaloncology.com
Published: Aug. 3, 2026, 3:31 p.m.
Segment Analysis and Major Growth Areas in the Endometrial Cancer Treatment Market - openPR.com
Segment Analysis and Major Growth Areas in the Endometrial Cancer Treatment Market openPR.com
Published: Aug. 3, 2026, 10:50 a.m.
Segment Analysis and Major Growth Areas in the Endometrial Cancer Treatment Market - openpr.com
Segment Analysis and Major Growth Areas in the Endometrial Cancer Treatment Market openpr.com
Published: Aug. 3, 2026, 10:50 a.m.
Endometrial Cancer Market Expected to Witness Significant - openPR.com
Endometrial Cancer Market Expected to Witness Significant openPR.com
Published: Aug. 2, 2026, 5:51 p.m.
Karyopharm (KPTI) Shares Collapse 65% After Xpovio Fails Endometrial Cancer Trial Again - londoninsider.co.uk
Karyopharm (KPTI) Shares Collapse 65% After Xpovio Fails Endometrial Cancer Trial Again londoninsider.co.uk
Published: Aug. 1, 2026, 8:33 a.m.
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial Vanguard
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial The Clinical Trial Vanguard
Published: Aug. 1, 2026, 6:33 a.m.
Karyopharm To Stick With Blood Cancers As Xpovio Flops In Endometrial Cancer - insights.citeline.com
Karyopharm To Stick With Blood Cancers As Xpovio Flops In Endometrial Cancer insights.citeline.com
Published: July 31, 2026, 8:31 p.m.
Link copied to clipboard!